Btochelylirftl INTERACTIONS INVOLVING PARASITTE Clavicepx Purpurea

Total Page:16

File Type:pdf, Size:1020Kb

Btochelylirftl INTERACTIONS INVOLVING PARASITTE Clavicepx Purpurea 1. BTOCHElYlirftl INTERACTIONS INVOLVING PARASITTE Clavicepx purpurea A thesis presented in fulfilment of the requirements for the degree of Ph.D. of the University of London by JULIA WILLINGALE April 1983 Department of Biochemistry, Imperial College of Science and Technology, London, SU7. 2. BIOCHEMICAL INTERACTIONS INVOLVING PARASTIC CJavicens PURPUREA ABSTRACT Artificial inoculation of wheat, infected with the bunt fungus Tilletia caries with Claviceps purpurea strain 12/2 [ALK~] resulted in a dual infection of the host ovary. Spatial interaction between the two pathogens during concurrent occupation of the ovary were studied by immunofluorescent microscopy, based on antibody raised against C. purpurea glucanase. Experiments on the specificity of this antibody showed no cross reaction with the mycelium of T. caries grown in axenic culture. Using this apparent specificity the investigations revealed penetration through the integument wall at the base of the ovary. Within 5 days, T. caries teliospores, at the base of the ovary, had been displaced in an acropetal direction by sporing,sphacelial tissue of C, purpurea. Establishment of the sphacelium was marked by copious honeydew exudation. At the fungal-fungal interface teliospores were completely surrounded by Claviceps hyphae. Above and below this interface, free teliospores and homogeneous sphacelial tissue were evident. As growth and differentiation to sclerotial tissue occurred, the bunted region became pushed to the tip of the developing ergot, forming a cap of black teliospores. During parasitic development on rye, a strain of Claviceps purpurea produced the primary pathway precursor dimethylaliyltryptophan (DMAT) but no tetracyclic ergoline alkaloids. Incubation of fresh sclerotial tissue with radioactively labelled primary pathway precursors demonstrated the biosynthesis of DMAT during the incubation period from tryptophan and mevalonate. There was no chromatographic evidence of N-methyl DMAT the next intermediate in ergoline biosynthesis. This was confirmed by a more sensitive approach in which it was found that 14C-methyl methionine was not incorporated into any indolic 3. metabolite. Thus the biosynthetic block was located beyond DFIAT at the step DMAT to N-methyl DMAT. Further inv/estigation into the operation of later steps in the ergoline pathway were explored by incubating parasitic tissue with 1^C-agroclauine, prepared biosynthetically by fermentation of C. fusiformis, and lysergic acid. Addition of the alkaloid intermediates did not result in production of the ergoline alkaloids usually formed by C. purpurea, but both promoted the biosynthesis of a single product, novel in C. purpurea, identified as lysergic acid amide. This strain of C. purpurea therefore has potential for exploring the control of the tryptophan prenylation step and provides new evidence concerning the role of lysergic acid amide in the biosynthesis of the cyclic tripeptide ergot alkaloids. Preliminary experiments suggest that at physiological concentrations phosphate does not inhibit the prenylation step. To compare the relative toxicity of alkaloid-free ergot and ergot rich in ergotoxine, young lean and obese mice were fed diets containing ergot. Animals on diets containing alkaloid-free ergot maintained a normal growth rate when a 10% ergot diet was given. In contrast mice consuming ergot rich in alkaloid became anorexic, and further administration of a diet containing 3% ergot was lethal. A group of mycotoxins which are structually related to the ergot alkaloids are the indole containing tremorgens, the most potent of which is verruculogen. TR-2 a structually related derivative of verruculogen was successfully incorporatec into verruculogen and fumitremorgen B by submerged culture of P. raistrickii . The finding that this tremorgenic alkaloid can be readily prenylated and therefore act as an intermediate in the biosynthesis of verruculogen is of some ecological interest when considering the possible role of soil-borne fungi in " staggers" syndromes. There are undoubtedly idiopathic syndromes amoungst livestock which occur due to synergistic effects of exo- mycotoxins. Tremorgenic species of Aspergillus and Penicillium commonly mould grain and grain products. Poor storage could easily have resulted in the proliferation of these ubiquitous, saprophytic moulds on ergotised grain, the consumption of which might have resulted in dominant expression of the neurological toxicity rather than the vasopressor type charactoristic of ergot alkaloids. Therefore a possible role for tremorgenic mycotoxins in convulsive ergotism, the cause of which is still in doubt, is discussed. 4. TABLE OF CONTENTS PAGE Abstract 2 Table of Contents 4 Index of Figures 7 Index of Tables 9 Index of Plates 10 Acknowlegements 11 1. INTRODUCTION 12 1.1 Ergot fungi as plant pathogens 12 1.1.1 Life cycle 12 1.1.2 Plant disease aetiology 14 1.1.3 Interaction between Claviceps 15 ptirpureaand the common bunt fungus Tilletia caries. 1.1.4 The role of fungal 8-1-3, 18 glucanases in plant pathogenicity 1.2 Ergot alkaloids 23 1.2.1 Chemistry 23 1.2.2 Biosynthesis 29 1.2.3 Regulation and control of alkaloid 37 biosynthesis 113.Toxicity 40 1.3.1 Ergotism and Nan 40 1.3.2 Toxicity in livestock 42 1.4.Tremorgenic mycotoxins 45 2. NATERIALS AND METHODS 51 2.1.Growth and maintenance'of fungi 51 2.1.1 Ergot 51 2.1.2 Penicillium spp. 52 2.2.General analytical methods 53 2.2.1 Detection and isolation of ergot 53 alkaloids 2.2.2 Layer chromatography (TLC and PLC) 54 5. 2.2.3 High performance liquid 55 chromatography (HPLC) 2.2.4 Centrifugation 55 2.2.5 Detection and assay of 56 biosynthetically radiolabelled metabolites 2.3 Axenic culture of the common bunt 57 fungus Tilletia caries 2.4 3-glucanase activity of wheat ovary 65 tissue infected with C. purpurea strain 12/2 and T, caries 2.5 3-glucanase activity of T• caries 69 grown in axenic culture 2^6 Immunofluorescent technique to 70 study spatial interaction between C. pupurea and T. caries during concurrent parasitism of the host ovary 2.7 Detection and promotion of ergot 77 alkaloid biosynthesis in C. purpurea strain 12/2 [ALK~] 2.8 Biosynthesis of verruculogen 82 2.8.1 Incorporation of radiolabelled TR-2 82 into verruculogen and fumitremorgen B by P. raistrickii 2.8.2 Incorporation of ll*C-proline into 88 verruculogen related metabolites of P. simplicissimum 2.9 Toxicity of ergot sclerotia gg 2.9.1 Preliminary investigation into the '90 effect on growth of young lean mice and young obese mice, resulting from the ingestion of sclerotial tissue of C. purpurea 2.9.2 Statistical analysis 93 3. RESULTS 94 3.1 Growth of T. caries in axenic culture 94 3.2 3-glucanase activity during the early 102 stage of ovary infection 3.3 3-glucanase activity of T. caries in 102 axenic culture 3.4 Spatial interaction between C, purpurea 107 and T. caries during concurrent parasitism of wheat ovary tissue 3.5 Biosynthesis 119 3.6.1 Incorporation of radiolabelled 14C-TR-2 into verruculogen and fumitremorgen B by P. raistrickii 3.6.2 Application of the fluorimetric assay to fumitremorgen B 3.6.3 Biosynthetically-radiolabelled, verruculogen related,metabolites of P. simplicissimum 3.7 Toxicity 4. DISCUSSION 4.1 8-glucanase activity of T. caries 4.2 Interaction between C, purpurea and T. caries in wheat ovary tissue 4.3 Promotion of alkaloid biosynthesis in a Q\LK J C. purpurea mutant 4.4 Biosynthesis of verruculogen 4.5 Toxicity APPENDIX I Technique to reduce unwanted background fluorescence in fluorescence microscopy APPENDIX II Preparation of plant tissue for fluorescence microscopy APPENDIX III Statistical analysis for the difference between two sample means 5. REFERENCES INDEX OF FIGURES 'PAGE Fig. 1 Life cycle of ergot 13 Fig. 2 Life cycle of bunt Tilletia caries 17 Fig. 3 The tetracyclic ergoline ring system 23 Fig. 4 Biosynthetic origin of the tetracyclic 32 ergoline ring Fig. 5 Relationships between clavine alkaloids 35 Fig. 6 Chemical structure of tremorgenic 47 mycotoxins of the paspalinine group Fig. 7 Structure of verruculogen 48 Fig. 8 Chemical structure of the fumitremorgens 49 Fig. 9 Chemical structure of TR-2 49 Fig.ID Four populations of bunt teliospores 58 obtained by centrifugation Fig.11 Diagramatic representation of longitudinal 67 section through a bunt infected ovary at "anthesis" Fig.12 Elution of IgG fractions of 3-1,3 glucanase 72 antiserum fr.Dma DEAE-cellulose column Fig.13 Resolution of C-verruculogen and llfC- 85 fumitremorgen B by HPLC Fig.14 HPLC extract of fumitremorgen B left in 87 aqueous solution for 6h; repurified by HPLC Fig.15 Resolution of fumitremorgen B by HPLC 87 Fig.16 3-glucanase activity of control and 165 infected ovaries with increasing age Fig.17 3-glucanase activity of control, 104 "healthy bunted", and infected bunted ovaries with increasing age of infection Fig.18 Time course of hydrolysis of S. sorghi 106 glucan by dialysed extracts of T. caries tissue from axenic culture Fig.19 Diagramatic representation of a dual ^11 infected wheat ovary, 6 days after inoculation with C, purpurea 8. Fig.20 Diagramatic representation of a 113 longitudinal section through a dual infected ovary, 10 days after inoculation with C, purpurea Fig.21 Diagram representing sections of dual 123 infected ovaries stained with (3-1,3 glucanase antiserum, indicating the areas of the sections illustrated in Plate 8 and 9 Fig.22 Incubation of fresh parasitic tissue 126 of C. purpurea strain 12/2 [ALK"] with C-methyl methionine. TLC analysi s Fig.23 Incubation of fresh parasitic tissue 130 of C, purpurea strain 12/2 [ALK~] with 1^C-tryptophan in the presence of O.OIM 0.1M and 1.01*1 phosphate Fig.24 Excitation and emission spectra for 136 acid-treated verruculogen and fumitremorgen B Fig.25 Growth curves for 3 groups of obese mice 140 A & B over the 50 day experimental period Fig.26 Growth curves for 3 groups of lean mice 142 A & B over the 50 day experimental period Fig.27 Limitation of, and potential for, ergot 158 alkaloid biosynthesis in a mutant strain of C.
Recommended publications
  • Ergot Alkaloids Mycotoxins in Cereals and Cereal-Derived Food Products: Characteristics, Toxicity, Prevalence, and Control Strategies
    agronomy Review Ergot Alkaloids Mycotoxins in Cereals and Cereal-Derived Food Products: Characteristics, Toxicity, Prevalence, and Control Strategies Sofia Agriopoulou Department of Food Science and Technology, University of the Peloponnese, Antikalamos, 24100 Kalamata, Greece; [email protected]; Tel.: +30-27210-45271 Abstract: Ergot alkaloids (EAs) are a group of mycotoxins that are mainly produced from the plant pathogen Claviceps. Claviceps purpurea is one of the most important species, being a major producer of EAs that infect more than 400 species of monocotyledonous plants. Rye, barley, wheat, millet, oats, and triticale are the main crops affected by EAs, with rye having the highest rates of fungal infection. The 12 major EAs are ergometrine (Em), ergotamine (Et), ergocristine (Ecr), ergokryptine (Ekr), ergosine (Es), and ergocornine (Eco) and their epimers ergotaminine (Etn), egometrinine (Emn), egocristinine (Ecrn), ergokryptinine (Ekrn), ergocroninine (Econ), and ergosinine (Esn). Given that many food products are based on cereals (such as bread, pasta, cookies, baby food, and confectionery), the surveillance of these toxic substances is imperative. Although acute mycotoxicosis by EAs is rare, EAs remain a source of concern for human and animal health as food contamination by EAs has recently increased. Environmental conditions, such as low temperatures and humid weather before and during flowering, influence contamination agricultural products by EAs, contributing to the Citation: Agriopoulou, S. Ergot Alkaloids Mycotoxins in Cereals and appearance of outbreak after the consumption of contaminated products. The present work aims to Cereal-Derived Food Products: present the recent advances in the occurrence of EAs in some food products with emphasis mainly Characteristics, Toxicity, Prevalence, on grains and grain-based products, as well as their toxicity and control strategies.
    [Show full text]
  • First Xenon-Xenon Collisions in the Lhc
    9th International Particle Accelerator Conference IPAC2018, Vancouver, BC, Canada JACoW Publishing ISBN: 978-3-95450-184-7 doi:10.18429/JACoW-IPAC2018-MOPMF039 FIRST XENON-XENON COLLISIONS IN THE LHC M. Schaumann∗, R. Alemany-Fernandez, P. Baudrenghien, T. Bohl, C. Bracco, R. Bruce, N. Fuster-Martinez, M. A. Jebramcik, J.M. Jowett, T. Mertens, D. Mirarchi, S. Redaelli, B. Salvachua, M. Solfaroli, H. Timko, J. Wenninger, CERN, Geneva, Switzerland Abstract EXECUTION OF THE RUN In 2017, the CERN accelerator complex once again demonstrated its flexibility by producing beams of a new A total of about 18 h of LHC time were taken for the Xe ion species, xenon, that were successfully injected into LHC. collision run. The schedule was designed to include set-up, On 12 October, collisions of fully stripped xenon nuclei first injection, validation and physics data taking. A further 12 h were devoted to experiments on crystal collimation, de- were recorded for the first time in the LHC√ at a centre-of- scribed elsewhere [3]. This tight schedule was only feasible mass energy per colliding nucleon pair of sNN = 5.44 TeV. Physics data taking started 9.5hafter the first injection of by drastically reducing the complexity of the set-up follow- xenon beams and lasted a total of 6h. The integrated lumi- ing the model of the p–Pb pilot run in September 2012 [4,5] nosity delivered to the four LHC experiments was sufficient when first injection, validation and physics data-taking were that new physics results can be expected soon. We provide achieved within a single fill.
    [Show full text]
  • XENON X-1100 High-Intensity Pulsed Light System
    XENON X-1100 High-Intensity Pulsed Light System The low cost R&D tool for investigating the applicability of Pulsed Light for new and emerging applications. The tool that researchers, scientists and engineers have been looking for is here. An easy-to-use photonic system developed by XENON that will open new doors and lead to new discoveries. The power of Pulsed Light In virtually all disciplines of science and technology there are applications where precise delivery of energy is demanded. One less studied energy delivery mechanism is the use of high-intensity pulsed light. At present the most prevalent example of this is in the use of lasers. However, the point source, coherent and single wavelength nature of lasers, are often not suited to the majority of challenges facing many industries. In these situations, it is crucial to have a broad spectra source so as not to be restricted in choosing materials with specific absorption characteristics. Because XENON sources generate light which extends from the deep UV to IR and often with peak pulse powers measured in megawatts, the ability of these sources to perform tasks such as breaking chemical bonds, sintering, ablating or sterilizing is highly realizable. The high peak powers generated by XENON’s production level systems are possible by tightly controlling the pulse durations measured from a few microseconds to milliseconds. Until now there was no practical method of generating this intense pulsed light in a low-cost R&D tool that was safe, compact and versatile. XENON has developed a system to address this challenge based on over 50 years of exper- tise in the Pulsed Light industry.
    [Show full text]
  • Pharmacology – Inhalant Anesthetics
    Pharmacology- Inhalant Anesthetics Lyon Lee DVM PhD DACVA Introduction • Maintenance of general anesthesia is primarily carried out using inhalation anesthetics, although intravenous anesthetics may be used for short procedures. • Inhalation anesthetics provide quicker changes of anesthetic depth than injectable anesthetics, and reversal of central nervous depression is more readily achieved, explaining for its popularity in prolonged anesthesia (less risk of overdosing, less accumulation and quicker recovery) (see table 1) Table 1. Comparison of inhalant and injectable anesthetics Inhalant Technique Injectable Technique Expensive Equipment Cheap (needles, syringes) Patent Airway and high O2 Not necessarily Better control of anesthetic depth Once given, suffer the consequences Ease of elimination (ventilation) Only through metabolism & Excretion Pollution No • Commonly administered inhalant anesthetics include volatile liquids such as isoflurane, halothane, sevoflurane and desflurane, and inorganic gas, nitrous oxide (N2O). Except N2O, these volatile anesthetics are chemically ‘halogenated hydrocarbons’ and all are closely related. • Physical characteristics of volatile anesthetics govern their clinical effects and practicality associated with their use. Table 2. Physical characteristics of some volatile anesthetic agents. (MAC is for man) Name partition coefficient. boiling point MAC % blood /gas oil/gas (deg=C) Nitrous oxide 0.47 1.4 -89 105 Cyclopropane 0.55 11.5 -34 9.2 Halothane 2.4 220 50.2 0.75 Methoxyflurane 11.0 950 104.7 0.2 Enflurane 1.9 98 56.5 1.68 Isoflurane 1.4 97 48.5 1.15 Sevoflurane 0.6 53 58.5 2.5 Desflurane 0.42 18.7 25 5.72 Diethyl ether 12 65 34.6 1.92 Chloroform 8 400 61.2 0.77 Trichloroethylene 9 714 86.7 0.23 • The volatile anesthetics are administered as vapors after their evaporization in devices known as vaporizers.
    [Show full text]
  • Xenon Gas Xe Safety Data Sheet SDS P4677
    Xenon Safety Data Sheet P-4677 This SDS conforms to U.S. Code of Federal Regulations 29 CFR 1910.1200, Hazard Communication. Date of issue: 01/01/1979 Revision date: 10/24/2016 Supersedes: 10/02/2014 SECTION: 1. Product and company identification 1.1. Product identifier Product form : Substance Name : Xenon CAS No : 7440-63-3 Formula : Xe Other means of identification : Xenon 1.2. Relevant identified uses of the substance or mixture and uses advised against Use of the substance/mixture : Industrial use. Use as directed. 1.3. Details of the supplier of the safety data sheet Praxair, Inc. 10 Riverview Drive Danbury, CT 06810-6268 - USA T 1-800-772-9247 (1-800-PRAXAIR) - F 1-716-879-2146 www.praxair.com 1.4. Emergency telephone number Emergency number : Onsite Emergency: 1-800-645-4633 CHEMTREC, 24hr/day 7days/week — Within USA: 1-800-424-9300, Outside USA: 001-703-527-3887 (collect calls accepted, Contract 17729) SECTION 2: Hazard identification 2.1. Classification of the substance or mixture GHS-US classification Compressed gas H280 2.2. Label elements GHS-US labeling Hazard pictograms (GHS-US) : GHS04 Signal word (GHS-US) : WARNING Hazard statements (GHS-US) : H280 - CONTAINS GAS UNDER PRESSURE; MAY EXPLODE IF HEATED OSHA-H01 - MAY DISPLACE OXYGEN AND CAUSE RAPID SUFFOCATION Precautionary statements (GHS-US) : P202 - Do not handle until all safety precautions have been read and understood P271+P403 - Use and store only outdoors or in a well-ventilated place CGA-PG05 - Use a back flow preventive device in the piping CGA-PG10 - Use only with equipment rated for cylinder pressure CGA-PG06 - Close valve after each use and when empty CGA-PG02 - Protect from sunlight when ambient temperature exceeds 52°C (125°F) 2.3.
    [Show full text]
  • Nematotoxicity of Neotyphodium Infected Tall Fescue Alkaloids and Other Secondary Metabolites on Pratylenchus Scribneri
    NEMATOTOXICITY OF NEOTYPHODIUM-INFECTED TALL FESCUE ALKALOIDS AND OTHER SECONDARY METABOLITES ON THE PLANT- PARASITIC NEMATODE PRATYLENCHUS SCRIBNERI by ADA ANTONIA BACETTY (Under the direction of Charles W. Bacon) ABSTRACT Tall fescue (Festuca arundinacea) is a perennial, cool-season turf and forage grass species in the United States that covers over 20 million hectares of pastureland. Neotyphodium coenophialum, an endophytic fungus associated with cool-season grasses, enhances host fitness and imparts pest resistance to the grass. Biologically active alkaloids and other secondary metabolites are produced in this association that not only cause adverse effects on livestock, fescue toxicosis, but may also play a role in the reduction of plant-parasitic nematode populations. Currently there is little information available on the effects of these biologically active compounds on nematodes associated with tall fescue. Therefore, this research examines the interaction of ergot and loline alkaloids, as well as polyphenolic compounds, from endophyte-infected tall fescue on toxicity to the lesion nematode, Pratylenchus scribneri. In vitro bioassays were performed to assess the effects of specifically identified compounds on P. scribneri motility, mortality, and chemoreception. While separate greenhouse studies evaluated the effects of endophyte- infected tall fescue on P. scribneri viability. Root extracts served as nematistatic agents to the nematodes in the chemical submersion assays and affected nematode behavior by acting as repellents in chemoreception studies. During individual tests, ergovaline and α-ergocryptine were nematicidal at 5µg/ml and 50µg/ml respectively. However, chemotaxis studies revealed α-ergocryptine as an attractant (1-20µg/ml) and repellent (50-200µg/ml). Ergovaline was an effective repellent (1-5µg/ml) and a nematicidal (10-200µg/ml).
    [Show full text]
  • Ergot Alkaloid Biosynthesis in Aspergillus Fumigatus : Association with Sporulation and Clustered Genes Common Among Ergot Fungi
    Graduate Theses, Dissertations, and Problem Reports 2009 Ergot alkaloid biosynthesis in Aspergillus fumigatus : Association with sporulation and clustered genes common among ergot fungi Christine M. Coyle West Virginia University Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Coyle, Christine M., "Ergot alkaloid biosynthesis in Aspergillus fumigatus : Association with sporulation and clustered genes common among ergot fungi" (2009). Graduate Theses, Dissertations, and Problem Reports. 4453. https://researchrepository.wvu.edu/etd/4453 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. Ergot alkaloid biosynthesis in Aspergillus fumigatus: Association with sporulation and clustered genes common among ergot fungi Christine M. Coyle Dissertation submitted to the Davis College of Agriculture, Forestry, and Consumer Sciences at West Virginia University in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Genetics and Developmental Biology Daniel G. Panaccione, Ph.D., Chair Kenneth P. Blemings, Ph.D. Joseph B.
    [Show full text]
  • Occurrence and Significance of Mycotoxins in Forage Crops And
    J Sci Food Agric 1998, 77,1È17 Occurrence and Signiücance of Mycotoxins in Forage Crops and Silage: a Review Keith A Scudamore1* and Christopher T Livesey2 1 Central Science Laboratory, London Road, Slough, Berks, SL3 7HJ, UK 2 Veterinary Laboratories Agency, New Haw, Woodham Lane, Addlestone, Surrey, KT15 3NB, UK (Received 5 December 1996; revised version received 29 May 1997; accepted 4 September 1997) Abstract: Study of mycotoxins in animal feeding stu†s has concentrated on the occurrence of aÑatoxins and, to a lesser extent, other mycotoxins in cereals, raw materials and concentrate feeds. However, ruminant diets contain a high propor- tion of forage crops such as grass or maize silage, hay and straw. Under adverse growing, production or storage conditions, fungal spoilage is likely to occur with some degree of mycotoxin contamination. The mould Ñora of forage crops is likely to di†er signiÐcantly from that of cereals and mycotoxin contamination, should it occur, could di†er qualitatively and quantitatively. Information relating to forage crops as a potential source of mycotoxins is reviewed. Some Ðeld inci- dents and animal disease which may be mycotoxin related are discussed and analytical methods are reviewed. Information on dose and e†ect of candidate mycotoxins is given where available. The review suggests areas which the authors consider merit further study. Crown Copyright 1998. J Sci Food Agric 77,1È17 (1998) Key words: mycotoxins; fungi; moulds; silage; forage crops; hay; straw; occurrence; analysis; risk assessment; animal disease INTRODUCTION access, silage will be at risk from storage moulds such as Penicillium and Aspergillus. However, moulds may be During growth, forage crops are at risk in the Ðeld from aerobic or anaerobic and this means that, even if infection by a number of di†erent fungi, some of which oxygen is excluded, some moulds may be able to may produce mycotoxins.
    [Show full text]
  • United States Patent
    Patented Aug. 17, 1948 2,447,214 UNITED STATES PATENT OFF ICE 2,447,214 OPTICALLY ACTIVE SALTS OF THE LY SERGIC AND SOLYSERGIC ACD DE RVATIVES AND A PROCESS FOR, THER PREPARATION AND SOLATION Arthur Stoll and Albert Hofmann, Basel, Switzer land, assignors to Sandoz Ltd., Fribourg, Swit zerland, a Swiss firm No Drawing. Application August 23, 1943, Serial No. 499,714. In Switzerland September 16, 1942 16 Claims. (CI. 260-236) 2 The preparation and the isolation of the thera The synthetically prepared derivatives of the peutically valuable and active derivatives con lysergic acid which also correspond to the above tained in ergot is a problem that has occupied cited formula possess also the same lability as chemistry and pharmacy for more than 120 years. the natural lysergic acid derivatives. Their is0 Actually it is known that the action of ergot is 5 lation and preparation encounters the same dif due to the alkaloids contained therein, which have ficulties as in the case of the lysergic acid hydra been isolated in recent years and which are zides C15H15N2CONHNH2 (made according to U. S. always present as pairs of isomers. Chrono Letters Patent 2,090,429) and in the case of the logically the following alkaloids have become alkaloids of the type of ergobasine, which can be 0 prepared by partial synthesis and in which the known up to noW: lysergic acid is combined with an amine in form Ergotinine (1875). Ergotoxine (1906) of an acid amide (see U. S. Letters Patent No. Ergotamine (1918) Ergotaminine (1918) 2,090,430).
    [Show full text]
  • Risk Assessment of Argyreia Nervosa
    Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos Risk assessment of Argyreia nervosa RIVM letter report 2019-0210 W. Chen | L. de Wit-Bos RIVM letter report 2019-0210 Colophon © RIVM 2020 Parts of this publication may be reproduced, provided acknowledgement is given to the: National Institute for Public Health and the Environment, and the title and year of publication are cited. DOI 10.21945/RIVM-2019-0210 W. Chen (author), RIVM L. de Wit-Bos (author), RIVM Contact: Lianne de Wit Department of Food Safety (VVH) [email protected] This investigation was performed by order of NVWA, within the framework of 9.4.46 Published by: National Institute for Public Health and the Environment, RIVM P.O. Box1 | 3720 BA Bilthoven The Netherlands www.rivm.nl/en Page 2 of 42 RIVM letter report 2019-0210 Synopsis Risk assessment of Argyreia nervosa In the Netherlands, seeds from the plant Hawaiian Baby Woodrose (Argyreia nervosa) are being sold as a so-called ‘legal high’ in smart shops and by internet retailers. The use of these seeds is unsafe. They can cause hallucinogenic effects, nausea, vomiting, elevated heart rate, elevated blood pressure, (severe) fatigue and lethargy. These health effects can occur even when the seeds are consumed at the recommended dose. This is the conclusion of a risk assessment performed by RIVM. Hawaiian Baby Woodrose seeds are sold as raw seeds or in capsules. The raw seeds can be eaten as such, or after being crushed and dissolved in liquid (generally hot water).
    [Show full text]
  • United States Patent (19) [11] 3,968,111 Bach Et Al
    United States Patent (19) [11] 3,968,111 Bach et al. (45) July 6, 1976 54 8,8-DISUBSTITUTED-6- 3,113,133 12/1963 Hofmann et al..w. 260/285.5 METHYLERGOLINES AND RELATED COMPOUNDS Primary Examiner-Alton D. Rollins 75) inventors: Nicholas J. Bach; Edmund C. Assistant Examiner-Mary Vaughn Kornfeld, both of Indianapolis, Ind. Attorney, Agent, or Firm-James L. Rowe, Everet F. 73) Assignee: Eli Lilly and Company, Indianapolis, Smith Ind. 22 Filed: Dec. 6, 1974 21 Appl. No.: 530,320 57 ABSTRACT 8,8-Disubstituted-6-methylergolines and 9-ergolenes, 52 U.S. Cl............................... 260/285.5; 424/261 prepared by alkylation of lysergic, isolysergic or their 51 int. C.’................ C07D 457/02; C07D 457/10 9,10-dihydro analogues, optionally followed by chemi 58) Field of Search.................................. 260/285.5 cal modification of an 8-substituent. 56 References Cited UNITED STATES PATENTS 9 Claims, No Drawings 2,86,074 1 1/1958 Kornfeld et al.................. 260/285.5 3,968, 111 1 2 1722 (1957) prepared the 8-methyl derivative of D-iso 8,8-DISUBSTITUTED-6-METHYLERGOLINES AND lysergic acid diethylamide, stating that they were, how RELATED COMPOUNDS ever, unable to obtain substitution at C8 using dihydro lysergic acid methyl ester and the alkylating agent used BACKGROUND OF THE INVENTION successfully with lysergic acid itself; to wit, methylio Compounds based on the ergoline ring system dide and potassium amide. These authors also prepared 8-ethyl-D-isolysergic acid diethylamide and the 1,8- dimethyl-D-isolysergic acid diethylamide. There is no mention in the literature of an 8,8-disubstituted-9-ergo O lene in which the substituents at 8 are other than amide groups and in which the 1-position is not substituted.
    [Show full text]
  • Genetics, Genomics and Evolution of Ergot Alkaloid Diversity Carolyn A
    University of Kentucky UKnowledge Plant Pathology Faculty Publications Plant Pathology 4-2015 Genetics, Genomics and Evolution of Ergot Alkaloid Diversity Carolyn A. Young The Samuel Roberts Noble Foundation Christopher L. Schardl University of Kentucky, [email protected] Daniel G. Panaccione West Virginia University Simona Florea University of Kentucky, [email protected] Johanna E. Takach The Samuel Roberts Noble Foundation See next page for additional authors Right click to open a feedback form in a new tab to let us know how this document benefits oy u. Follow this and additional works at: https://uknowledge.uky.edu/plantpath_facpub Part of the Plant Pathology Commons Repository Citation Young, Carolyn A.; Schardl, Christopher L.; Panaccione, Daniel G.; Florea, Simona; Takach, Johanna E.; Charlton, Nikki D.; Moore, Neil; Webb, Jennifer S.; and Jaromczyk, Jolanta, "Genetics, Genomics and Evolution of Ergot Alkaloid Diversity" (2015). Plant Pathology Faculty Publications. 45. https://uknowledge.uky.edu/plantpath_facpub/45 This Article is brought to you for free and open access by the Plant Pathology at UKnowledge. It has been accepted for inclusion in Plant Pathology Faculty Publications by an authorized administrator of UKnowledge. For more information, please contact [email protected]. Authors Carolyn A. Young, Christopher L. Schardl, Daniel G. Panaccione, Simona Florea, Johanna E. Takach, Nikki D. Charlton, Neil Moore, Jennifer S. Webb, and Jolanta Jaromczyk Genetics, Genomics and Evolution of Ergot Alkaloid Diversity Notes/Citation Information Published in Toxins, v. 7, no. 4, p. 1273-1302. © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
    [Show full text]